The Cooper Companies, Inc.

(NASDAQ Global Select)
Back to all articles
Somewhat Bullish +45

What Makes Cooper Companies (COO) an Investment Choice?

AI-generated analysis

πŸ“ˆ The London Company Mid Cap Strategy featured The Cooper Companies (COO) as a top holding in its Q4 2025 investor letter.

πŸ’° CooperVision accounts for over 65% of revenue, operating in an oligopolistic contact lens market where four players control 95% share.

πŸ“‰ Shares lost 8.17% over the last 52 weeks but closed at $83.56 per share on February 24, 2026, with a market cap of $16.6 billion.

πŸ› οΈ Margins currently trail peers due to a multi-year investment cycle and industry headwinds affecting the medical device sector.

πŸš€ Significant margin expansion potential exists as capital spending moderates and capacity utilization improves in the coming quarters.

πŸ‘” Activist involvement is identified as a key catalyst for operational improvements and potential business separation of divisions.

πŸ’Ό Recent insider buying signals confidence in the company's long-term fundamentals despite recent cyclical price weakness.

πŸ“Š 53 hedge fund portfolios held COO at the end of Q4 2025, down from 56 in the previous quarter.

🧠 The London Company suggests AI stocks may offer higher returns and shorter time frames compared to Cooper's current profile.

πŸ₯ Cooper operates two distinct segments: CooperVision (contact lenses) and CooperSurgical (women's healthcare products).

Bullish Signals
  • CooperVision dominates a high-quality, oligopolistic market with four players controlling 95% of the industry, providing strong pricing power.
  • The company possesses a diverse product portfolio and deep customer relationships that drive above-market growth rates.
  • High customer switching costs create a durable competitive moat within the contact lens and women's healthcare segments.
  • Valuation is currently attractive relative to peers, presenting a potential entry point for long-term investors.
  • Recent insider buying activity signals management confidence in the company's future prospects despite recent stock weakness.
  • Activist involvement serves as a catalyst for operational improvements and could lead to strategic business separation.
  • Significant margin expansion potential is available as capital spending moderates and capacity utilization improves.
Risk Factors
  • Current operating margins trail peers due to a multi-year investment cycle and ongoing industry headwinds.
  • The stock has lost 8.17% of its value over the last 52 weeks, reflecting recent cyclical pressures and execution missteps.
  • Cooper is not included in the list of 30 most popular stocks among hedge funds, indicating lower institutional consensus compared to peers.
  • Hedge fund holdings decreased from 56 portfolios in the previous quarter to 53 at the end of Q4 2025.
Full Analysis
The London Company's fourth-quarter 2025 investor letter highlights The Cooper Companies, Inc. (NASDAQ: COO) as a featured holding within its Mid Cap Strategy portfolio. While the broader market saw gains in Q4 2025, the strategy outperformed the Russell Midcap Index, driven by specific stock selection and sector exposure that included positions in medical device firms like Cooper. Cooper operates through two main segments: CooperVision, which generates over 65% of revenue from contact lenses in an oligopolistic market with four dominant players, and CooperSurgical, focused on women's healthcare products. The company benefits from high customer switching costs and a diverse product portfolio, though current margins are trailing peers due to ongoing capital investments and industry headwinds. Investment analysts note that recent share price weakness is attributed to cyclical pressures and execution issues rather than fundamental deterioration. Key bullish factors include significant potential for margin expansion as capital spending moderates, attractive valuation levels, and insider buying signaling confidence. Additionally, activist involvement is cited as a potential catalyst for operational improvements and possible business separation. Despite these strengths, the article notes that Cooper is not currently among the top 30 most popular stocks held by hedge funds, with holdings dropping slightly from 56 to 53 portfolios in Q4 2025. The London Company suggests that while Cooper offers promise, other AI-focused stocks may offer higher returns and shorter time frames for investors seeking aggressive growth.